Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 8—August 2025
Online Report
Optimal Timing for Expanding Diagnostic Laboratories, South Korea
Figure 4

Figure 4. Diagnostic laboratory expansion for Middle East respiratory syndrome (MERS) and COVID-19, South Korea. Number of MERS cases during May–July 2015 (A) and number of COVID-19 cases during January–March 2020 (B) were compared. Red arrow and dotted vertical lines indicate when testing was expanded to include private medical testing laboratories. Gray curved arrows indicate when testing was conducted using RUO-approved or EUA-approved reagents. RUOs were used to implement new MERS diagnostic tests, and EUAs were used for novel COVID-19 diagnostic tests. EUA, emergency use authorization; RUO, research-use only.